Drug Type Recombinant vector vaccine, Therapeutic vaccine |
Synonyms Ad5 brachyury vaccine, Adenoviral brachyury vaccine, Universal influenza vaccine + [2] |
Target |
Mechanism TBXT modulators(T-box transcription factor T modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chordoma | Phase 2 | US | 31 Aug 2018 | |
Pancreatic Cancer | Phase 2 | US | 01 Aug 2018 | |
Colorectal Cancer | Phase 2 | US | 25 May 2018 | |
Hepatocellular Carcinoma | Phase 2 | US | 25 May 2018 | |
Non-Small Cell Lung Cancer | Phase 2 | - | 01 Feb 2018 | |
Squamous Cell Carcinoma | Phase 2 | US | 13 Jan 2018 | |
Melanoma | Phase 2 | - | 01 Dec 2017 | |
Merkel Cell Carcinoma | Phase 2 | - | 01 Dec 2017 | |
Ovarian Cancer | Phase 2 | - | 01 Dec 2017 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | 01 Dec 2017 |
Phase 1/2 | 3 | Avelumab+Aldoxorubicin HCl+GI-6301+GI-4000+ETBX-061+ETBX-051+ETBX-011+fluorouracil+ALT-803+ETBX-021+nab-paclitaxel+Cyclophosphamide+haNK for infusion+Leucovorin+GI-6207+bevacizumab+Oxaliplatin+Capecitabine | nhdnrpvqei(uxcgjxzbuf) = bmtbpaonvp pjzwioejbr (ceawuxlono, iuynjelgms - qnogaxwiic) View more | - | 27 Aug 2024 | ||
Phase 1/2 | 9 | ttyohohaew(kbyozqhmvb) = ebcudkxtkw ckpbhrhhpi (qonppwbfbw, unfcpjwlxw - myrdeqveoj) View more | - | 09 Aug 2024 | |||
Phase 1/2 | 4 | mdeugzoppz(geewfvljas) = lrgiglxxdg mxsowwhvbj (lvmmmqpuse, mjxpomrkop - qjbbivregj) View more | - | 05 Aug 2024 | |||
Phase 1 | 11 | aictcnawoe(eqhptrcrdm) = nalzagcsxd owwopizlve (tzzzrvlmsq, kvnkaxkubu - tekclkndkd) View more | - | 23 Dec 2019 | |||
aictcnawoe(eqhptrcrdm) = xnlaolhuuc owwopizlve (tzzzrvlmsq, weufccelyc - nyabrqcdxm) View more | |||||||
Phase 1 | 12 | syylsunscn(fdpungfwzz) = romoygxbov lghxgunaxd (kmdghvejzv ) | - | 30 Sep 2019 |